Live tape
Top 8, mentions 7d10,771GOOGL2,061 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,187 mentions▲ +0.08META1,015 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

RCUS

Arcus Biosciences, Inc. · NYSE

$27.38 +1.41% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$35 $20 20 May 17 Jul

The line runs $23.74 on 20 May through $27.38 on 17 July, on a scale from $20 to $35. Days the market did not trade hold the previous close, flat.

The chart above plots the price of RCUS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $23.74 on 20 May 2026 through $27.38 on 17 July 2026.

Market cap $3.5B
52-week range $9 – $31.01
Avg volume 273.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

RCUS insider trades

SEC Form 4 · last 90 days · newest reported trade 10 Jul 2026
Open-market buys 0
Open-market sells 6
Net sold $2.98M
Non-trade filings 8
Date Insider Type Shares Value
10 Jul 2026 Jaen Juan C. President Sell 20,067 $574K
09 Jul 2026 Jaen Juan C. President Sell 48,502 $1.46M
24 Jun 2026 Jaen Juan C. President Sell 6,431 $191K
23 Jun 2026 Jaen Juan C. President Sell 15,764 $437K
22 Jun 2026 Jaen Juan C. President Sell 9,236 $250K
01 Jun 2026 Azoy Alexander Chief Accounting Officer Sell 2,562 $66K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Jun 2026 PERLMAN ANDREW J Director Award 5,700
11 Jun 2026 FALBERG KATHRYN E Director Award 5,700
11 Jun 2026 KANEKO YASUNORI Director Award 5,700
11 Jun 2026 Machado Patrick Director Award 5,700
11 Jun 2026 Lacey David L. Director Award 5,700
11 Jun 2026 Lambert Nicole Director Award 5,700
11 Jun 2026 Ribas Antoni Director Award 5,700
11 Jun 2026 Tang Carolyn C. General Counsel Option exercise 34,090 $88K

RCUS reported financials

SEC EDGAR XBRL

RCUS reported revenue of $33.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$353.0M.

Figure Reported Period
Revenue $33.0M 31 Dec 2025 fiscal year
Net income −$353.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.29 31 Dec 2025 fiscal year
Total assets $924.0M 30 Jun 2026 at period end
Total equity $464.0M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

RCUS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.72 $41M
31 Mar 2026 Q1 2026 $-1.02 $17M
31 Dec 2025 FY 2025 $-3.29 $247M
30 Sep 2025 Q3 2025 $-1.27 $26M
30 Jun 2025 Q2 2025 $0.00 $160M
31 Mar 2025 Q1 2025 $-1.14 $28M
31 Dec 2024 FY 2024 $-3.14 $258M
30 Sep 2024 Q3 2024 $-1.00 $48M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

RCUS institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a RCUS position for the quarter ended 30 Jun 2026 — a combined $282.8M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Citadel Advisors Added +135.7% shares 3,135,057 $96.7M
Fisher Asset Management Held (±25%) −2.3% shares 2,139,396 $66.0M
Marshall Wace Trimmed −48.3% shares 1,945,088 $60.0M
Baker Bros. Advisors Added +103.3% shares 844,816 $26.0M
Two Sigma Investments Added +103.2% shares 635,404 $19.6M
Man Group Added +70.4% shares 137,763 $4.2M
Millennium Management New position 133,110 $4.1M
D. E. Shaw & Co. Trimmed −62.8% shares 96,417 $3.0M
AQR Capital Management Held (±25%) −2.8% shares 83,861 $2.6M
Balyasny Asset Management New position 22,845 $704K

Source: SEC EDGAR 13F filings

RCUS fails-to-deliver

SEC CNS data

On 29 Jul 2026, 92,120 shares of RCUS failed to deliver (about $2.5M).

Settlement date Shares failed Notional % of shares out
29 Jul 2026 92,120 $2.5M 0.072%
20 Jul 2026 301 $8K <0.001%
16 Jul 2026 83 $2K <0.001%
14 Jul 2026 2 $56 <0.001%
09 Jul 2026 1,578 $48K 0.001%

Source: SEC fails-to-deliver (CNS) data